JP2023521149A5 - - Google Patents
Info
- Publication number
- JP2023521149A5 JP2023521149A5 JP2022561644A JP2022561644A JP2023521149A5 JP 2023521149 A5 JP2023521149 A5 JP 2023521149A5 JP 2022561644 A JP2022561644 A JP 2022561644A JP 2022561644 A JP2022561644 A JP 2022561644A JP 2023521149 A5 JP2023521149 A5 JP 2023521149A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- sequence
- adenovirus
- gene
- cell line
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025159003A JP2025175172A (ja) | 2020-04-07 | 2025-09-25 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063006266P | 2020-04-07 | 2020-04-07 | |
| US63/006,266 | 2020-04-07 | ||
| PCT/US2021/025890 WO2021207136A1 (en) | 2020-04-07 | 2021-04-06 | Adenoviral expression vector and methods and cell lines for production |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159003A Division JP2025175172A (ja) | 2020-04-07 | 2025-09-25 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521149A JP2023521149A (ja) | 2023-05-23 |
| JP2023521149A5 true JP2023521149A5 (https=) | 2024-03-29 |
| JP7750858B2 JP7750858B2 (ja) | 2025-10-07 |
Family
ID=75660398
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561644A Active JP7750858B2 (ja) | 2020-04-07 | 2021-04-06 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
| JP2025159003A Pending JP2025175172A (ja) | 2020-04-07 | 2025-09-25 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159003A Pending JP2025175172A (ja) | 2020-04-07 | 2025-09-25 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12227754B2 (https=) |
| EP (1) | EP4133090A1 (https=) |
| JP (2) | JP7750858B2 (https=) |
| KR (1) | KR20230008069A (https=) |
| CN (1) | CN115916984A (https=) |
| AU (1) | AU2021251718A1 (https=) |
| CA (1) | CA3174985A1 (https=) |
| IL (1) | IL297178A (https=) |
| WO (1) | WO2021207136A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250091839A (ko) | 2023-12-14 | 2025-06-23 | 김현우 | 강판의 부식방지용 페인트 자동 제거장치 |
| WO2025160234A1 (en) * | 2024-01-26 | 2025-07-31 | Cystic Fibrosis Foundation | Cftr super exon constructs and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094974C (zh) * | 1998-12-31 | 2002-11-27 | 上海华晨生物技术研究所 | 表达人白细胞介素12的重组腺病毒及其制法和用途 |
| US7553494B2 (en) | 2001-08-24 | 2009-06-30 | Corixa Corporation | WT1 fusion proteins |
| US20040142893A1 (en) * | 2002-10-21 | 2004-07-22 | Uichi Ikeda | Methods for treating and preventing vascular disease |
| US7026164B2 (en) * | 2003-07-03 | 2006-04-11 | Cell Genesys, Inc. | Adenovirus packaging cell lines |
| WO2005012537A2 (en) | 2003-07-25 | 2005-02-10 | Genvec, Inc. | Adenoviral vector-based vaccines |
| AU2005243730B2 (en) * | 2004-04-12 | 2010-05-27 | Genvec, Inc. | Method of using adenoviral vectors to induce an immune response |
| US7851218B2 (en) | 2004-12-13 | 2010-12-14 | Schering Corporation | Cell lines for production of replication-defective adenovirus |
| WO2007134325A2 (en) * | 2006-05-15 | 2007-11-22 | Introgen Therapeutics, Inc. | Methods and compositions for protein production using adenoviral vectors |
| CN103966263A (zh) * | 2013-02-04 | 2014-08-06 | 广州医学院第一附属医院 | 一种重组人3型腺病毒及其制备方法和应用 |
| US9624510B2 (en) * | 2013-03-01 | 2017-04-18 | The Wistar Institute | Adenoviral vectors comprising partial deletions of E3 |
| GB201620968D0 (en) * | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| US10738282B2 (en) * | 2016-12-20 | 2020-08-11 | Salk Institute For Biological Studies | Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses |
| CN111356763B (zh) | 2017-09-22 | 2024-03-12 | 建新公司 | 变体RNAi |
| CN112292449A (zh) * | 2018-04-09 | 2021-01-29 | 萨克生物研究学院 | 具有增强的复制特性的溶瘤腺病毒组合物 |
-
2021
- 2021-04-06 US US17/223,785 patent/US12227754B2/en active Active
- 2021-04-06 KR KR1020227038222A patent/KR20230008069A/ko active Pending
- 2021-04-06 EP EP21721343.8A patent/EP4133090A1/en active Pending
- 2021-04-06 IL IL297178A patent/IL297178A/en unknown
- 2021-04-06 JP JP2022561644A patent/JP7750858B2/ja active Active
- 2021-04-06 CN CN202180040972.1A patent/CN115916984A/zh active Pending
- 2021-04-06 AU AU2021251718A patent/AU2021251718A1/en active Pending
- 2021-04-06 CA CA3174985A patent/CA3174985A1/en active Pending
- 2021-04-06 WO PCT/US2021/025890 patent/WO2021207136A1/en not_active Ceased
-
2025
- 2025-01-08 US US19/013,469 patent/US20250137013A1/en active Pending
- 2025-09-25 JP JP2025159003A patent/JP2025175172A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12084654B2 (en) | Methods for using transcription-dependent directed evolution of AAV capsids | |
| JP7832262B2 (ja) | 肝特異的ウイルスプロモーター及びその使用方法 | |
| JP2023509964A5 (https=) | ||
| JP2008518591A5 (https=) | ||
| JPH07509616A (ja) | 欠陥アデノウイルスおよび対応補足系 | |
| JP2024511621A5 (https=) | ||
| JP2023521149A5 (https=) | ||
| JP2007500017A5 (https=) | ||
| CN116426573A (zh) | 重编程因子抗衰老表达系统、生物材料及用途 | |
| CN104212802A (zh) | 一种肿瘤细胞广谱高活性启动子及其用途 | |
| CN111447954A (zh) | 用于恢复hbb基因功能的腺相关病毒组合物及其使用方法 | |
| AU2023379677A1 (en) | Adenoviral helper plasmid | |
| JP7736329B2 (ja) | Ｄｕｘ４遺伝子を標的とした顔面肩甲上腕型筋ジストロフィーの治療方法 | |
| JPH11506311A (ja) | 遺伝子治療用のアデノウイルスベクター | |
| US20250019667A1 (en) | Adenoviral helper plasmid | |
| US7226779B2 (en) | Hybrid adenoviral vector | |
| WO2021230385A1 (en) | Method for treating muscular dystrophy by targeting utrophin gene | |
| US20250064986A1 (en) | Optimized polynucleotides for protein expression | |
| WO2022145495A1 (en) | Method for treating spinocerebellar ataxias (sca) by targeting atxn7 gene | |
| US20090061488A1 (en) | Method of synthesizing a target polynucleotide encoding a protein | |
| WO2023147558A2 (en) | Crispr methods for correcting bag3 gene mutations in vivo | |
| WO2023190935A1 (en) | Method for treating myopathies by targeting titin gene | |
| RU2801848C1 (ru) | Генетическая конструкция, адаптированная для доставки гена SMN1 человека с помощью аденоассоциированного вируса серотипа 2 для обеспечения нейроспецифичной экспрессии | |
| EP4570260A1 (en) | Viral vector for transduction of adipocytes | |
| WO2022176859A1 (en) | Method for treating muscular dystrophy by targeting lama1 gene |